Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial

Meir Schechter, Gil Leibowitz, Ofri Mosenzon

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	1698
Journal	Annals of Translational Medicine
Volume	8
Issue number	24
DOIs	https://doi.org/10.21037/atm-2020-117
State	Published - Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9e770f52f32d476ba05ae45c3b50387d,

title = "Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial",

author = "Meir Schechter and Gil Leibowitz and Ofri Mosenzon",

year = "2020",

month = dec,

doi = "10.21037/atm-2020-117",

language = "American English",

volume = "8",

pages = "1698",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

number = "24",

}

TY - JOUR

T1 - Paving the way to precision medicine for diabetic kidney disease

T2 - the PRIORITY trial

AU - Schechter, Meir

AU - Leibowitz, Gil

AU - Mosenzon, Ofri

PY - 2020/12

Y1 - 2020/12

U2 - 10.21037/atm-2020-117

DO - 10.21037/atm-2020-117

M3 - Article

C2 - 33490210

SN - 2305-5839

VL - 8

SP - 1698

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

IS - 24

ER -